Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Europe
The global rise of carbapenemase-producing Enterobacteriaceae (CPE) is alarming and is an increasing threat to patient safety, in Europe and globally.
ECDC welcomes WHO’s Global Guidelines for the Prevention of Surgical Site Infections
Today, the World Health Organization publishes its Global Guidelines for the Prevention of Surgical Site Infections, which include a list of recommendations prepared by top leading experts and based on a review of the latest evidence in the area.
Estimated burden of healthcare-associated infections higher than that of other infectious diseases such as influenza, HIV/AIDS and tuberculosis together, study says
A study published today by PLOS Medicine, estimates the combined burden of six healthcare-associated infections as being higher than that of diseases such as influenza, HIV/AIDS and tuberculosis together.
US CDC report on antibiotic resistance threats in the United States, 2013
Antimicrobial resistance represent a serious threat to public health and patient safety and is a worldwide problem. Each year, in the European Union (EU) at least 25 000 patients die of infections with multidrug-resistant bacteria.
US CDC guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) – 2012 CRE toolkitArchived
Carbapenem-resistant Enterobacteriaceae (CRE) or carbapenemase-producing Enterobacteriaceae (CPE) are highly resistant to antibiotics, leaving only a few options for treatment of infected patients, and thus represent a serious threat to public health.
Clostridium difficile infection in Europe: a hospital-based surveyArchived
Clostridium difficile infection is the leading cause of healthcare-associated diarrhoea in the developed world and represents a major financial burden for European healthcare systems.
Infection control measures to limit the spread of Clostridium difficileArchived
Clostridium difficile infection (CDI) is an intestinal infection usually acquired in hospital settings, after antibiotic treatment. The clinical spectrum of CDI ranges from mild diarrhoea to severe life-threatening pseudomembranous colitis. In the recent years, an increased incidence of CDI has been reported in Europe and worldwide.
Country-to-country transfer of patients and the risk of multi-resistant bacterial infectionArchived
This review outlines how increasing modalities of travel, such as aeromedical evacuation of civilians and of military personnel, medical tourism and any shared healthcare across countries, are risks for the transmission of multidrug-resistant organisms via the patient, from country to country.
Imported methicillin-resistant Staphylococcus aureus, SwedenArchived
The authors analyzed data on 444 imported cases of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden during the period 2000-2003. The risk for MRSA carriage or infection in returning travellers ranged from 0.1 per million travellers returning from Nordic countries to 59.4 per million travellers returning from North Africa and the Middle East.
Panton-Valentine leukocidin-positive Staphylococcus aureus infections in returning travelersArchived
The authors present data on 15 individuals infected by Panton-Valentine leukocidin (PVL) -producing strains of Staphylococcus aureus. Intra-familial spread was documented in one case, and occupational transmission was most likely in another case. spa typing of the strains revealed a broad range of variants, though some strains were clonally related. Methicillin-resistant Staphylococcus aureus (MRSA) was found in three cases.